Drug: rituximab Quarter: 2016Q3
Total Records: 1,104 Number of Pages: 56
DRUGNAME | PT | EventCount |
---|---|---|
RITUXIMAB | Pathogen resistance | 6 |
Rituximab | Peripheral swelling | 6 |
RITUXIMAB | Prescribed underdose | 6 |
rituximab | Protein total decreased | 6 |
RITUXIMAB | Rash maculo-papular | 6 |
rituximab | Skin reaction | 6 |
Rituximab | Skin ulcer | 6 |
Rituximab | Small intestinal resection | 6 |
Rituximab | Spinal compression fracture | 6 |
Rituximab | Transient ischaemic attack | 6 |
RITUXIMAB | Vaccine virus shedding | 6 |
RITUXIMAB | Venoocclusive liver disease | 6 |
rituximab | Vitamin B12 increased | 6 |
RITUXIMAB | White matter lesion | 6 |
RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Fatigue | 6 |
RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Febrile neutropenia | 6 |
RITUXIMAB | Abdominal abscess | 5 |
Rituximab | Adverse drug reaction | 5 |
RITUXIMAB | Arrhythmia | 5 |
RITUXIMAB | Atypical pneumonia | 5 |
Total Records: 1,104 Number of Pages: 56